Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines

NCT05970887 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Immune Response
Safety

Interventions

BIOLOGICAL: bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
BIOLOGICAL: quadrivalent influenza vaccine

Sponsor

Catholic Kwandong University

Collaborators

[object Object]